For many contract manufacturers, the end of the COVID-19 pandemic—and the production contracts that came with it—marked a ...

A campaign backed by Kyowa Kirin, Amgen and Sanofi is calling on prominent organizations with medical websites to bring their ...

That includes the concept of microfeminism, where Pelletier admitted to being “a little bit nervous” about “swinging for the ...

AbbVie and its subsidiary Allergan have had a long run of unchallenged success in the market with cosmetic and therapeutic ...

With the threat of tariffs looming for medicines imported to the United States, AstraZeneca has unveiled a plan to invest $50 ...

Amid plans to transfer manufacturing for an investigational vaccine to a souped-up plant in Pennsylvania, GSK is parting ways ...

The PMCPA ruled that “a systemic failure in compliance oversight” at Theramex has brou | The PMCPA ruled that “a systemic ...

Avalyn Pharma has added on $100 million to accelerate novel inhaled versions of approved drugs for lung conditions. The company’s series D fundraise was led by Suvretta Capital Management and SR One ...

As the controversy over the safety of Sarepta Therapeutics’ gene therapies comes to a head, the biotech is standing firm ...

AstraZeneca is raising its defenses against Johnson & Johnson in a fierce competition in EGFR-mutated non-small cell lung ...

FDA Commissioner Marty Makary, M.D., has made his pick for the next director of the FDA’s Center for Drug Evaluation and ...

The prospect of Lundbeck and Otsuka’s Rexulti becoming part of a new treatment for post-traumatic stress disorder (PTSD) ...